An observational study in Pregnancy Complications, Preeclampsia and Placental Abruption, sponsored by Tel-Aviv Sourasky Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2007-12-13.
Sponsored by Tel-Aviv Sourasky Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Pregnancy Complications with a site in Israel — 3 open to participants now, 3 under way, none of them phase 3. Pregnancy Complications · Israel.
Among the 12 studies in Pregnancy Complications with a site in Israel, this one is the only one that started in 2000, is one of 7 observational ones, and was the 2nd registered.
411 studies on the registry are indexed under Pregnancy Complications; 112 are open to participants now.
Browse Pregnancy Complications studies →3 of the 12 studies in Pregnancy Complications with a site in Israel are open now. Recruiting first, the newest first:
University Hospital, Basel, Switzerland · Sites in Israel, United States, Argentina and 6 more countries
Ages 18+ · Women only
Tel-Aviv Sourasky Medical Center · Sites in Israel
Women only
Wolfson Medical Center · Sites in Israel
Ages 18+ · Women only
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 91 Pregnancy Complications studies recruiting now, 44 (48%) set no upper age limit and 44 (48%) stop at 75 or younger; 22 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 45 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 1 started in 2000.
This study's planned enrollment of 100 is below the median of 400 across 198 observational studies indexed under Pregnancy Complications.
Median enrollment 200 across the 5 interventional studies, 320 across the 7 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 10 most frequent:
Tel-Aviv Sourasky Medical Center is the lead sponsor of 554 studies on the registry; 51 are open to participants now.
Tel-Aviv Sourasky Medical Center has 3 studies filed under Pregnancy Complications — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Pregnancy Complications with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Congenital and acquired thrombophilia were identified as risk factors for thrombosis in systemic vessels.Thrombophilias have also been recently found to be associated with preeclampsia, intrauterine fetal growth restriction (IUGR), placental abruption, intrauterine fetal death (IUFD) and repeated pregnancy loss.These severe pregnancy complications are thought to result from thrombotic events occurring in the uteroplacental circulation. Accumulating data have established an association between elevated plasma activity of factor VIII and thrombosis although the mechanism is still not defined and elevated factor VIII activity is now regarded as being equivalent to thrombophilia.
We intend to investigatthe association between factor VIII levels and severe pregnancy complications which are considered to result from placental vascular pathology, i.e., preeclampsia, IUGR, placental abruption and IUFD. We hypothezise that the prevalence of elevated factor 8 will be higher among women with pregnancy complications compared to controls.
women who had either normal pregnancy or complicated pregnancy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The study group included 49 patients with a previous history of one or more of the following pregnancy complications: preeclampsia (n = 17), severe IUGR (n = 13), IUFD (n = 14) or placental abruption (n = 5).
The control group included 49 healthy women who delivered during the study period, who did not smoke during pregnancy and in whom pregnancy and delivery were uneventful
prevalenc of elevated factor VIII
Time frame: RETROSPECTIVE
The record gives a start of Jan 2000 and a completion of Jan 2008. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Dec 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tel-Aviv Sourasky Medical Center →